NCT00982345View on ClinicalTrials.gov

Brain Imaging of Quetiapine Response in Anxious Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Major Depression
Interventions
DRUG

quetiapine (Seroquel XR)

Seroquel XR (starting dose 100mg and increased up to 400 mg as tolerated) treatment.

Trial Locations (1)

46202

Indiana University Adult Psychiatry Clinic, Indianapolis

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Indiana University School of Medicine

OTHER